Literature DB >> 4639029

Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine. An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone.

J H Oppenheimer, H L Schwartz, M I Surks.   

Abstract

6-n-propylthiouracil (PTU) administered to male Sprague-Dawley rats maintained on 2 and 5 mug L-thyroxine (T(4))/100 g body weight resulted in a marked reduction in the rate of conversion of L-thyroxine to L-triiodothyronine (T(3)). These effects could not be ascribed to induced hypothyroidism since the group maintained on 5 mug T(4)/day had normal levels of liver mitochondrial alpha glycerophosphate dehydrogenase. In confirmation of previous studies, PTU also reduced the fractional rate of deiodination of T(3). These observations provide a possible explanation of the many published observations indicating that PTU antagonizes the tissue effects of T(4) but not of T(3). The data suggest that monodeiodination of T(4) but not of T(3) is essential before hormonal effects can be manifested at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4639029      PMCID: PMC292418          DOI: 10.1172/JCI107063

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  ALPHA-GLYCEROPHOSPHATE DEHYDROGENASE RESPONSE TO THYROXINE IN THYROIDECTOMIZED, THIOURACIL-FED AND TEMPERATURE-ADAPTED RATS.

Authors:  W R RUEGAMER; W W WESTERFELD; D A RICHERT
Journal:  Endocrinology       Date:  1964-12       Impact factor: 4.736

2.  Propylthiouracil and hepatic clearance of thyroid hormones.

Authors:  S LANG; B N PREMACHANDRA
Journal:  Am J Physiol       Date:  1963-01

3.  The effects of triiodo-L-thyronine and L-thyroxine on the oxygen consumption and body weights of rats fed on a diet containing 0.05 percent propylthiouracil.

Authors:  A C HSIEH
Journal:  J Endocrinol       Date:  1963-03       Impact factor: 4.286

4.  Antigoitrogenic and calorigenic activities of thyroxine analogues in rats.

Authors:  N R STASILLI; R L KROC; R I MELTZER
Journal:  Endocrinology       Date:  1959-01       Impact factor: 4.736

5.  Effect of an anti-thyroxine compound on the metabolism of radioactive thyroxine and triiodothyronine in rats.

Authors:  J H WILKINSON; N F MACLAGAN
Journal:  Lancet       Date:  1953-11-14       Impact factor: 79.321

6.  Effect of 3:5:3-L-triiodothyronine and certain anti-thyroxine substances on the oxygen consumption of mice.

Authors:  N F MACLAGAN; W E SPROTT; J H WILKINSON
Journal:  Lancet       Date:  1952-11-08       Impact factor: 79.321

7.  The identification of 3:5:3'-L-triiodothyronine in human plasma.

Authors:  J GROSS; R PITT-RIVERS
Journal:  Lancet       Date:  1952-03-01       Impact factor: 79.321

8.  [Influence of 2-thiouracil and thiamazole on the activity of rat liver L-alpha-glycerophosphate oxidase as a function of L-thyroxine, L-3',3,5-triiodothyronine and L-3'-isopropyl-3,5-diiodothyronine].

Authors:  F J Seif; H Guglielmi
Journal:  Acta Endocrinol (Copenh)       Date:  1969-04

9.  Effects of thiouracil on rat liver alpha-glycerophosphate dehydrogenase and serum PBI responses to L-thyroxine.

Authors:  W R Ruegamer; J S Warren; M Barstow; W Beck
Journal:  Endocrinology       Date:  1967-08       Impact factor: 4.736

10.  Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects.

Authors:  L E Braverman; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

View more
  58 in total

1.  Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil.

Authors:  Y Israel; H Kalant; H Orrego; J M Khanna; L Videla; J M Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

2.  Conversion of thyroxine into tri-iodothyronine by rat liver homogenate.

Authors: 
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

3.  Type 2 iodothyronine deiodinase in human skeletal muscle: new insights into its physiological role and regulation.

Authors:  P Reed Larsen
Journal:  J Clin Endocrinol Metab       Date:  2009-06       Impact factor: 5.958

Review 4.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

5.  Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.

Authors:  J E Silva; P R Larsen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

6.  Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.

Authors:  M Saberi; F H Sterling; R D Utiger
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

7.  Iodothyronines: oxidative deiodination by hemoglobin and inhibition of lipid peroxidation.

Authors:  Y L Tseng; K R Latham
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

8.  Qualitative and quantitative differences in the pathways of extrathyroidal triiodothyronine generation between euthyroid and hypothyroid rats.

Authors:  J E Silva; M B Gordon; F R Crantz; J L Leonard; P R Larsen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

Authors:  M J Berry; D Grieco; B A Taylor; A L Maia; J D Kieffer; W Beamer; E Glover; A Poland; P R Larsen
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.

Authors:  D L Geffner; M Azukizawa; J M Hershman
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.